CN103055186A - External traditional Chinese medicine for treating ascites - Google Patents
External traditional Chinese medicine for treating ascites Download PDFInfo
- Publication number
- CN103055186A CN103055186A CN2013100367459A CN201310036745A CN103055186A CN 103055186 A CN103055186 A CN 103055186A CN 2013100367459 A CN2013100367459 A CN 2013100367459A CN 201310036745 A CN201310036745 A CN 201310036745A CN 103055186 A CN103055186 A CN 103055186A
- Authority
- CN
- China
- Prior art keywords
- parts
- ascites
- chinese medicine
- traditional chinese
- treating ascites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an externally used traditional Chinese medicine for treating ascites, which is prepared from the following medicinal materials in weight ratio: 50 parts of ratoon rice, 20 parts of australian cowplant root or leaf, 20 parts of gray vernonia, 30 parts of Astragalus mongholicus, 30 parts of grifola, 30 parts of black morning glory seeds, 30 parts of elecampane, 19 parts of frankincense, 28 parts of borneol, 30 parts of fried bighead atractylodes rhizome, 30 parts of fuling peel, 42 parts of semen plantaginis, 30 parts of Sculellaria barbata, 10 parts of Chinese lobelia, and 35 parts of small red bean. Clinical experiments prove that the externally used traditional Chinese medicine disclosed by the invention is capable of treating ascites safely and effectively.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of external application Chinese medicine for the treatment of ascites.
Background technology
Under the normal condition, a small amount of liquid (generally being less than 200ml) is arranged in the human abdominal cavity, to the intestinal peristalsis promoting lubricate, cause the intraperitoneal amount of liquid to increase when surpassing 200ml under any pathological state, be called ascites (ascites).Ascites only is a kind of symptom, and the ascitogenous cause of disease is a lot, relatively common are cardiovascular diseases, hepatopathy, peritoneopathy, nephropathy, malnutrition disease, the transfer of malignant tumor peritoneum, ovarian tumor, connective tissue disease etc.
When meeting patients with ascites clinically, should seek as soon as possible the cause of disease, treat for the cause of disease.But most ascitogenous cause of disease more complicated in the situation in the reality is difficult to make a definite diagnosis, and at this moment need to carry out necessary symptomatic treatment in order to alleviate the symptom that a large amount of ascites cause.Generally speaking, the treatment of ascites all is to take to put the operations such as ascites, concentrated ascites reinfusion, the backflow of ascites jugular vein.But use patient with operation painful large, medical expense is high.Still lack at present the effective medicine of generally recognized as safe.
Summary of the invention
The present invention aims to provide a kind of external application Chinese medicine for the treatment of ascites, by selecting suitable medical material and proportioning thereof, reaches the purpose of safe and effective healing ascites.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of external application Chinese medicine for the treatment of ascites, it is characterized in that, be prepared from by the medical material of following weight proportion: 50 parts of Herba Oryzae Reproductii, 20 parts of Radix Gymnematis Sylvestriss, 20 parts of rock spring grass, 30 parts of the Radixs Astragali, 30 parts of Polyporus, 30 parts of Semen Pharbitidis, 30 parts of the Radix Aucklandiae, 19 parts of Olibanums, 28 parts of Borneolum Syntheticums, 30 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 30 parts of Cortex Sclerotii Poriae, 42 parts of Semen Plantaginiss, 30 parts of Herba Scutellariae Barbataes, 10 parts of Herba Lobeliae Chinensis, 35 parts of Semen Ormosiae Hosiei.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
The inventor collects 40 routine agnogenic patients with ascites altogether between year March in October, 2009-2011.Age 42-65 year, course of disease 2-30 days.Be divided at random: treatment group 20 examples, matched group 40 examples.The data there was no significant differences such as two groups of ages, the state of an illness have comparability.
2, test method
2.1 the unguentum that treatment group external application the present invention makes according to specific embodiment 1, external application every day are once, keep more than 16 hours at every turn.One week of the course for the treatment of.
2.2 matched group adopts the conventional operative therapy that ascites combines with concentrated ascites reinfusion of putting.One week of the course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Produce effects: ascites is recovered normal level.Take a turn for the better: ascites alleviates, and the state of an illness is controlled.Invalid: without being clearly better, perhaps ascites continues to increase.
3.2 treatment statistical result sees Table 1.
Table 1 liang group curative effect relatively
| Group | n | Produce effects | Take a turn for the better | Invalid | Total effective rate (%) | The case of sapping one's vitality | Zhou Renjun medical fee (unit) |
| Treatment group | 20 | 5（25%） | 14 | 1 | 95% | 0 | 1032 |
| Matched group | 20 | 20（100%） | 0 | 0 | 10% | 7 | 17305 |
As seen, the medicine that the present invention makes can safe and effectively be controlled ascites, although curative effect unlike the routine operation therapy, therapeutic process is little to the human injury, and treatment cost is low, being applicable to a lot of old and family circumstances is not very well-to-do patient.
The specific embodiment
In order to understand better and to implement the present invention, further specify the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take by weighing: 50 parts of Herba Oryzae Reproductii, 20 parts of Radix Gymnematis Sylvestriss, 20 parts of rock spring grass, 30 parts of the Radixs Astragali, 30 parts of Polyporus, 30 parts of Semen Pharbitidis, 30 parts of the Radix Aucklandiae, 19 parts of Olibanums, 28 parts of Borneolum Syntheticums, 30 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 30 parts of Cortex Sclerotii Poriae, 42 parts of Semen Plantaginiss, 30 parts of Herba Scutellariae Barbataes, 10 parts of Herba Lobeliae Chinensis, 35 parts of Semen Ormosiae Hosiei.
An amount of vinegar of the last adding of levigation and Mel reconcile into cream altogether, namely get the unguentum that meets one day consumption of normal adult.Be used for the treatment of ascites, spread on the belly place outward, available gauze twines and wraps for the purpose of making things convenient for for taking action, and once a day, keeps more than 16 hours at every turn.
More than all medicines share play eliminating dampness by diuresis, except effect swollen, diuretic, it is evident in efficacy to eliminate ascites, drug safety no pain, and the treatment cost is low, obtains patient's extensive approval.
Claims (1)
1. external application Chinese medicine for the treatment of ascites, it is characterized in that, be prepared from by the medical material of following weight proportion: 50 parts of Herba Oryzae Reproductii, 20 parts of Radix Gymnematis Sylvestriss, 20 parts of rock spring grass, 30 parts of the Radixs Astragali, 30 parts of Polyporus, 30 parts of Semen Pharbitidis, 30 parts of the Radix Aucklandiae, 19 parts of Olibanums, 28 parts of Borneolum Syntheticums, 30 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 30 parts of Cortex Sclerotii Poriae, 42 parts of Semen Plantaginiss, 30 parts of Herba Scutellariae Barbataes, 10 parts of Herba Lobeliae Chinensis, 35 parts of Semen Ormosiae Hosiei.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100367459A CN103055186B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating ascites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100367459A CN103055186B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating ascites |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103055186A true CN103055186A (en) | 2013-04-24 |
| CN103055186B CN103055186B (en) | 2013-11-27 |
Family
ID=48098280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100367459A Expired - Fee Related CN103055186B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating ascites |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103055186B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1112442A (en) * | 1995-04-27 | 1995-11-29 | 陶振海 | Baicaoshengshou oral liquor and its preparation |
| CN1122721A (en) * | 1994-11-11 | 1996-05-22 | 王君 | Yin-Yang regulating liver function bag |
| CN1333039A (en) * | 2000-07-10 | 2002-01-30 | 张国平 | Poria repercussion powder medicine |
| CN1422641A (en) * | 2001-12-05 | 2003-06-11 | 李佩文 | Medicine for treating cancerous thoracoascites and preparation method |
| CN101732423A (en) * | 2008-11-18 | 2010-06-16 | 陈恒树 | Chinese medicinal pills for treating hepatosplenomegaly |
-
2013
- 2013-01-31 CN CN2013100367459A patent/CN103055186B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1122721A (en) * | 1994-11-11 | 1996-05-22 | 王君 | Yin-Yang regulating liver function bag |
| CN1112442A (en) * | 1995-04-27 | 1995-11-29 | 陶振海 | Baicaoshengshou oral liquor and its preparation |
| CN1333039A (en) * | 2000-07-10 | 2002-01-30 | 张国平 | Poria repercussion powder medicine |
| CN1422641A (en) * | 2001-12-05 | 2003-06-11 | 李佩文 | Medicine for treating cancerous thoracoascites and preparation method |
| CN101732423A (en) * | 2008-11-18 | 2010-06-16 | 陈恒树 | Chinese medicinal pills for treating hepatosplenomegaly |
Non-Patent Citations (2)
| Title |
|---|
| 邱向红 等: "肝硬化腹水中医药研究概况", 《现代消化及介入诊疗》 * |
| 黎琮毅 等: "肝硬化腹水的中医药治疗现状", 《江西中医药》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103055186B (en) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102198262A (en) | Chinese medicine preparation for treating infant rotavirus enteritis and preparation method thereof | |
| CN102579940B (en) | Chinese medicine composition for curing infantile diarrhea and applied on navel | |
| CN102670803B (en) | External used Chinese plaster applied onto navel for curing infantile diarrhea | |
| CN101011426B (en) | Medicated wine for treating cancer and preparing process thereof | |
| CN102240324B (en) | Compound medicament for treating dental ulcer | |
| CN103417812B (en) | TCM composition for treatment of femoral head necrosis and preparation method thereof | |
| CN103656365B (en) | A kind of Chinese medicine for the treatment of the hyperthyroidism of deficiency of YIN of both the heart and liver pattern of syndrome | |
| CN104740189A (en) | Traditional Chinese medicine composition for treating myasthenia gravis caused by deficiency of liver-yin and kidney-yin | |
| CN103784541A (en) | Traditional Chinese medicine for treating pains on neck, shoulders, waist and legs | |
| CN103055186B (en) | External traditional Chinese medicine for treating ascites | |
| CN107837380A (en) | A kind of Chinese medicine composition for treating cancer pain and preparation method thereof | |
| CN102698025B (en) | Traditional Chinese medicine preparation for treating female endocrine dyscrasia and preparation method thereof | |
| CN107929644A (en) | A kind of Chinese medicine composition for treating sinus bradycardia and preparation method thereof | |
| CN104523942B (en) | One treats colpitic external preparation | |
| CN102205102B (en) | Chinese medical plantar pain-relieving ointment for treating plantar fasciitis | |
| CN102772620B (en) | Medicine for inhibiting recurrence of cancer after surgery | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101810751B (en) | Chinese medicinal preparation for treating pediatric mesenteric lymph node inflammation | |
| CN105535852A (en) | Traditional Chinese medicine preparation for treating arrhythmia | |
| CN104208366A (en) | Chinese medicinal drug for treating marrow depletion and kidney deficiency syndrome tinnitus cerebri | |
| CN104027789A (en) | Traditional Chinese medicine composition for treating cold retardation type jaundice of newborn babies and preparing method thereof | |
| CN104547695B (en) | It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia | |
| CN104189850A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome | |
| CN103893740A (en) | Traditional Chinese medicine for treating chronic colitis | |
| CN103933529A (en) | Traditional Chinese medicine preparation for treating cardialgia caused by deficiency of heart-qi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131127 Termination date: 20180131 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |